Coherus BioSciences (NASDAQ:CHRS) Price Target Raised to $12.00 at HC Wainwright
Related Articles
-
Barclays Raises Phibro Animal Health (NASDAQ:PAHC) Price Target to $13.00
Phibro Animal Health (NASDAQ:PAHC – Get Free Report) had its price target lifted by research analysts at Barclays from $10.00 to $13.00 in a report issued on Friday, Benzinga reports. The firm presently has an “underweight” rating on the stock. Barclays‘s price objective points to a potential downside of 25.93% from the stock’s previous close. […]
-
Applied Materials (NASDAQ:AMAT) Price Target Raised to $255.00 at Wells Fargo & Company
Applied Materials (NASDAQ:AMAT – Free Report) had its target price upped by Wells Fargo & Company from $250.00 to $255.00 in a research note issued to investors on Friday morning, Benzinga reports. The brokerage currently has an overweight rating on the manufacturing equipment provider’s stock. Several other equities analysts have also issued reports on AMAT. […]
-
Tripadvisor (NASDAQ:TRIP) Price Target Cut to $20.00
Tripadvisor (NASDAQ:TRIP – Get Free Report) had its price target dropped by equities research analysts at UBS Group from $27.00 to $20.00 in a report issued on Thursday, Benzinga reports. The firm presently has a “neutral” rating on the travel company’s stock. UBS Group’s price target would indicate a potential upside of 10.01% from the […]